Renal denervation for treatment of cardiac arrhythmias: State of the art and future directions

Journal of Cardiovascular Electrophysiology

Volumn 26, Issue 2, 2015, Pages 233-238

  Kosiuk, Jedrzej ^a   Hilbert, Sebastian ^a   Pokushalov, Evgeny ^b   Hindricks, Gerhard ^a   Steinberg, Jonathan S ^c   Bollmann, Andreas ^a  

^a UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^b MESHALKIN NATIONAL MEDICAL RESEARCH CENTER   (Russian Federation)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

atrial fibrillation; autonomic nervous system; catheter ablation; renal denervation; ventricular tachycardia

Indexed keywords

ABLATION THERAPY; ADRENERGIC SYSTEM; CATHETER ABLATION; CONGESTIVE CARDIOMYOPATHY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM REMODELING; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; KIDNEY DENERVATION; KIDNEY NERVE; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; RESISTANT HYPERTENSION; REVIEW; SYMPATHETIC TONE; ANIMAL; ARRHYTHMIAS, CARDIAC; FORECASTING; HEART; INNERVATION; KIDNEY; MASS COMMUNICATION; PATHOPHYSIOLOGY; PROCEDURES; SYMPATHECTOMY; TREATMENT OUTCOME; TRENDS;

ANIMALS; ARRHYTHMIAS, CARDIAC; DIFFUSION OF INNOVATION; FORECASTING; HEART; HUMANS; KIDNEY; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 84922445131     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12553     Document Type: Review

References (31)

1. Lown B, Verrier RL,: Neural activity and ventricular fibrillation. N Engl J Med 1976; 294: 1165-1170.
2. Schwartz PJ, Priori SG, Cerrone M, Spazzolini C, Odero A, Napolitano C, Bloise R, De Ferrari GM, Klersy C, Moss AJ, Zareba W, Robinson JL, Hall WJ, Brink PA, Toivonen L, Epstein AE, Li C, Hu D,: Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation 2004; 109: 1826-1833.
3. Wilde AA, Bhuiyan ZA, Crotti L, Facchini M, De Ferrari GM, Paul T, Ferrandi C, Koolbergen DR, Odero A, Schwartz PJ,: Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med 2008; 358: 2024-2029.
4. Schwartz PJ, Priori SG,: Sympathetic nervous system and cardiac arrhythmias. In: Zipes DP, Jalife J, eds Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, PA: WB Saunders Co; 1990, pp. 330-343.
5. Schwartz PJ, Snebold NG, Brown AM,: Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am J Cardiol 1976; 37: 1034-1040.
6. Kadowaki MH, Levett JM,: Sympathectomy in the treatment of angina and arrhythmias. Ann Thorac Surg 1986: 41: 572-578.
7. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL,; SYMPLICITY HTN-3 Investigators: A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393-1401.
8. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD,: Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 2009; 361: 932-934.
9. Sobotka PA, Mahfoud F, Schlaich MP, Hoppe UC, Bohm M, Krum H,: Sympatho-renal axis in chronic disease. Clin Res Cardiol 2011; 100: 1049-1057.
10. Davies JE, Manisty CH, Petraco R, Barron AJ, Unsworth B, Mayet J, Hamady M, Hughes AD, Sever PS, Sobotka PA, Francis DP,: First-in-man safety evaluation of renal denervation for chronic systolic heart failure: Primary outcome from REACH-Pilot study. Int J Cardiol 2013; 162: 189-192.
11. Taborsky M, Lazarova ML, Vaclavik J,: The effect of renal denervation in patients with advanced heart failure. ESC-Munich 2012; 190 (3148).
12. Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger HR, Eick C, Sobotka PA, Gawaz M, Böhm M,. Renal sympathetic denervation for treatment of electrical storm: First-in-man experience. Clin Res Cardiol 2012; 101: 63-67.
13. Remo BF, Preminger M, Bradfield J, Mittal S, Boyle N, Gupta A, Shivkumar K, Steinberg JS, Dickfeld T,: Safety and efficacy of renal denervation as a novel treatment of ventricular tachycardia storm in patients with cardiomyopathy. Heart Rhythm 2014; 11: 541-546.
14. Hoffmann BA, Steven D, Willems S, Sydow K,: Renal sympathetic denervation as an adjunct to catheter ablation for the treatment of ventricular electrical storm in the setting of acute myocardial infarction. J Cardiovasc Electrophysiol 2013; 24: 1175-1178.
15. Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, Cosio F, Crijns H, Diener HC, Goette A, Israel CW, Kuck KH, Lip GY, Nattel S, Page RL, Ravens U, Schotten U, Steinbeck G, Vardas P, Waldo A, Wegscheider K, Willems S, Breithardt G,: Early and comprehensive management of atrial fibrillation: Executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference "research perspectives in AF." Eur Heart J 2009; 30: 2969-2977.
16. Nattel S,: New ideas about atrial fibrillation 50 years on. Nature 2002; 415: 219-226.
17. Wakili R, Voigt N, Kääb S, Dobrev D, Nattel S,: Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest 2011; 121: 2955-2968.
18. Allessie MA, Boyden PA, Camm AJ, Kléber AG, Lab MJ, Legato MJ, Rosen MR, Schwartz PJ, Spooner PM, Van Wagoner DR, Waldo AL,: Pathophysiology and prevention of atrial fibrillation. Circulation 2001; 103: 769-777.
19. Schotten U, Verheule S, Kirchhof P, Goette A,: Pathophysiological mechanisms of atrial fibrillation: A translational appraisal. Physiol Rev 2011; 91: 265-325.
20. Iwasaki YK, Nishida K, Kato T, Nattel S,: Atrial fibrillation pathophysiology: Implications for management. Circulation 2011; 124: 2264-2274.
21. Arora R,: Recent insights into the role of the autonomic nervous system in the creation of substrate for atrial fibrillation: Implications for therapies targeting the atrial autonomic nervous system. Circ Arrhythm Electrophysiol 2012; 5: 850-859.
22. Sharifov OF, Fedorov VV, Beloshapko GG, Glukhov AV, Yushmanova AV, Rosenshtraukh LV,: Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs. J Am Coll Cardiol 2004; 43: 483-490.
23. Oral H, Crawford T, Frederick M, Gadeela N, Wimmer A, Dey S, Sarrazin JF, Kuhne M, Chalfoun N, Wells D, Good E, Jongnarangsin K, Chugh A, Bogun F, Pelosi F Jr, Morady F,: Inducibility of paroxysmal atrial fibrillation by isoproterenol and its relation to the mode of onset of atrial fibrillation. J Cardiovasc Electrophysiol 2008; 19: 466-470.
24. Jayachandran JV, Sih HJ, Winkle W, Zipes DP, Hutchins GD, Olgin JE,: Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation 2000; 101: 1185-1191.
25. Shen MJ, Choi EK, Tan AY, Lin SF, Fishbein MC, Chen LS, Chen PS,: Neural mechanisms of atrial arrhythmias. Nat Rev Cardiol 2011; 9: 30-39.
26. Zhao Q, Yu S, Zou M, Dai Z, Wang X, Xiao J, Huang C,: Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing. J Interv Card Electrophysiol 2012; 35: 119-125.
27. Wang X, Zhao Q, Huang H, Tang Y, Xiao J, Dai Z, Yu S, Huang C,: Effect of renal sympathetic denervation on atrial substrate remodeling in ambulatory canines with prolonged atrial pacing. PLoS One 2013; 8: e64611.
28. Lau DH, Mackenzie L, Kelly DJ, Psaltis PJ, Brooks AG, Worthington M, Rajendram A, Kelly DR, Zhang Y, Kuklik P, Nelson AJ, Wong CX, Worthley SG, Rao M, Faull RJ, Edwards J, Saint DA, Sanders P,: Hypertension and atrial fibrillation: Evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model. Heart Rhythm 2010; 7: 1282-1290.
29. Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, Soliman EZ, Maclehose R, Konety S, Alonso A,: Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 2011; 123: 1501-1508.
30. Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A, Shirokova N, Karaskov A, Mittal S, Steinberg JS,: A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol 2013; 62: 1129-1130.
31. Vollmann D, Sossalla S, Schroeter MR, Zabel M,: Renal artery ablation instead of pulmonary vein ablation in a hypertensive patient with symptomatic, drug-resistant, persistent atrial fibrillation. Clin Res Cardiol 2013; 102: 315-318.